Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease
- PMID: 1575018
- DOI: 10.1007/BF00713534
Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease
Abstract
In two elderly patients with frontal lobe dementia and in two others with progressive aphasia an inverse relationship between the severity of beta protein deposition and the principal pathology of these disorders was noted. Deposition of beta protein occurred only in areas of cortex where functional (viable) neurones were still present and was absent where neuronal decimation had taken place. Such findings suggest that the presence of functional neurones is necessary for beta protein deposition to occur and, therefore, that neurones may be the source of the amyloid protein that is deposited within brain parenchyma not only in these disorders but also in other conditions, particularly Alzheimer's disease.
Similar articles
-
Pathologic findings in a case of primary progressive aphasia.Neurology. 1994 Feb;44(2):279-82. doi: 10.1212/wnl.44.2.279. Neurology. 1994. PMID: 8309574
-
Frontal lobe degeneration of non-Alzheimer type. Structural characteristics, diagnostic criteria and relation to other frontotemporal dementias.Acta Neurol Scand Suppl. 1996;168:28-30. Acta Neurol Scand Suppl. 1996. PMID: 8997416 Review.
-
Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method.Acta Neuropathol. 2001 Mar;101(3):256-70. doi: 10.1007/s004010000293. Acta Neuropathol. 2001. PMID: 11307626
-
Severity of cardiovascular disease, apolipoprotein E genotype, and brain pathology in aging and dementia.Ann N Y Acad Sci. 2000 Apr;903:244-51. doi: 10.1111/j.1749-6632.2000.tb06374.x. Ann N Y Acad Sci. 2000. PMID: 10818513
-
Pathophysiology of dementias and implications for therapy.Indian J Pathol Microbiol. 2005 Jul;48(3):289-99. Indian J Pathol Microbiol. 2005. PMID: 16761736 Review.
Cited by
-
Evidence for the experimental transmission of cerebral beta-amyloidosis to primates.Int J Exp Pathol. 1993 Oct;74(5):441-54. Int J Exp Pathol. 1993. PMID: 8217779 Free PMC article.
-
The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease.Acta Neuropathol Commun. 2018 Jul 20;6(1):62. doi: 10.1186/s40478-018-0563-8. Acta Neuropathol Commun. 2018. PMID: 30029687 Free PMC article.
-
The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence.J Clin Med. 2020 Jan 12;9(1):206. doi: 10.3390/jcm9010206. J Clin Med. 2020. PMID: 31940879 Free PMC article. Review.
-
Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer's disease.Acta Neuropathol Commun. 2013 Aug 12;1:50. doi: 10.1186/2051-5960-1-50. Acta Neuropathol Commun. 2013. PMID: 24252571 Free PMC article.
-
Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.Brain Struct Funct. 2010 Mar;214(2-3):263-83. doi: 10.1007/s00429-009-0235-3. Epub 2009 Dec 11. Brain Struct Funct. 2010. PMID: 20012092 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical